Skip to main content
Premium Trial:

Request an Annual Quote

Roche Gets FDA OK for HCV Viral Load Test

NEW YORK (GenomeWeb News) - Roche Molecular Diagnostics announced yesterday that it has received US Food and Drug Administration clearance for its hepatitis C viral load test.
The COBAS AmpliPrep/COBAS TaqMan HCV test is fully automated and uses Roche’s proprietary real-time PCR technology to quantify the amount of virus in an individual’s blood.
Now that the test has been given the green light in the US, physicians can use it to monitor viral load at baseline and during treatment to help determine the effectiveness of therapy. The test, which has been calibrated to World Health Organization traceable standards, can detect a broad dynamic viral range — from high levels to low levels once considered undetectable.
That, in turn, helps to predict treatment response from onset to completion. A clinical trial of the test in 1,281 patients reportedly validated the importance of viral load testing for personalized HCV treatment.
“This new Roche test enables laboratories to deliver reliable healthcare information with ease and allows physicians to more efficiently monitor their patients and improve treatment outcomes,” Roche Molecular Diagnostics President and CEO Daniel O’Day said in a statement.
Early last month, Roche received FDA clearance of the COBAS TaqMan hepatitis B viral load test. Its COBAS AmpliPrep/COBAS TaqMan system menu also includes an FDA approved HIV viral load test, which allows continuous loading of samples and parallel processing of HIV and HCV tests. More than 130 American laboratories already utilize the platform for HIV testing, according to Roche.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.